Ultrasound Contrast Agents Sector: Growth Drivers and Challenges
Growth Drivers
- Growing Use of Ultrasound Diagnosis
- Increasing Prevalence of Chronic Diseases Globally
Challenges
- Allergic Reactions and Side Effects
- Short Term Effect of the Agents
Browse key industry insights with market data tables & charts from the report:
Frequently Asked Questions (FAQ)
Ultrasound Contrast Agents Market size is set to expand at over 19.8% CAGR during the forecast period i.e., between 2025-2037.
Rising prevalence of chronic disorders and increasing implementation of ultrasound diagnosis will fuel the market growth.
Asia Pacific industry is poised to account for largest revenue share by 2037, owing to increasing necessity for advanced diagnosis methods to detect various disease indications such as neurological disorders, cancer, cardiovascular diseases, and others.
The major players in the market include Bristol-Myers Squibb, GE Healthcare, Lantheus Holdings, Inc., Bracco Diagnostic Inc., Siemens Healthcare GmbH, and others.
